Selected research
Industry Research
Oxycodone Industry Research Report 2026
Market perspective
The global Oxycodone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oxycodone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oxycodone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oxycodone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oxycodone include Teva Pharmaceuticals, Sun Pharmaceutical (Chattem Chemicals), Sanofi, Johnson & Johnson, Mylan, Pfizer, Purdue Pharma, Mallinckrodt and Indivior, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oxycodone market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oxycodone Market by Company
Teva Pharmaceuticals
Sun Pharmaceutical (Chattem Chemicals)
Sanofi
Johnson & Johnson
Mylan
Pfizer
Purdue Pharma
Mallinckrodt
Indivior
Impax Laboratories
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Endo International
Oxycodone Segment by Type
Long Acting Oxycodone
Short Acting Oxycodone
Oxycodone Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
Oxycodone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oxycodone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oxycodone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oxycodone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Acting Oxycodone
- Short Acting Oxycodone
Applications
- Hospital Pharmacies
- Retail Pharmacies
- Others
Companies covered
- Teva Pharmaceuticals
- Sun Pharmaceutical (Chattem Chemicals)
- Sanofi
- Johnson & Johnson
- Mylan
- Pfizer
- Purdue Pharma
- Mallinckrodt
- Indivior
- Impax Laboratories
- Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
- Endo International
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oxycodone Market Size (2021-2032)
- 2.2.2 Global Oxycodone Sales (2021-2032)
- 2.2.3 Global Oxycodone Market Average Price (2021-2032)
- 2.3 Oxycodone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Long Acting Oxycodone
- 2.3.3 Short Acting Oxycodone
- 2.4 Oxycodone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oxycodone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oxycodone Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Oxycodone Revenue of Manufacturers (2021-2026)
- 3.4 Global Oxycodone Average Price by Manufacturers (2021-2026)
- 3.5 Global Oxycodone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oxycodone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oxycodone, Product Type & Application
- 3.8 Global Manufacturers of Oxycodone, Established Date
- 3.9 Global Oxycodone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceuticals
- 4.1.1 Teva Pharmaceuticals Company Information
- 4.1.2 Teva Pharmaceuticals Business Overview
- 4.1.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceuticals Oxycodone Product Portfolio
- 4.1.5 Teva Pharmaceuticals Recent Developments
- 4.2 Sun Pharmaceutical (Chattem Chemicals)
- 4.2.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
- 4.2.2 Sun Pharmaceutical (Chattem Chemicals) Business Overview
- 4.2.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Portfolio
- 4.2.5 Sun Pharmaceutical (Chattem Chemicals) Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Oxycodone Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Johnson & Johnson
- 4.4.1 Johnson & Johnson Company Information
- 4.4.2 Johnson & Johnson Business Overview
- 4.4.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Johnson & Johnson Oxycodone Product Portfolio
- 4.4.5 Johnson & Johnson Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Oxycodone Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Oxycodone Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Purdue Pharma
- 4.7.1 Purdue Pharma Company Information
- 4.7.2 Purdue Pharma Business Overview
- 4.7.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Purdue Pharma Oxycodone Product Portfolio
- 4.7.5 Purdue Pharma Recent Developments
- 4.8 Mallinckrodt
- 4.8.1 Mallinckrodt Company Information
- 4.8.2 Mallinckrodt Business Overview
- 4.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mallinckrodt Oxycodone Product Portfolio
- 4.8.5 Mallinckrodt Recent Developments
- 4.9 Indivior
- 4.9.1 Indivior Company Information
- 4.9.2 Indivior Business Overview
- 4.9.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Indivior Oxycodone Product Portfolio
- 4.9.5 Indivior Recent Developments
- 4.10 Impax Laboratories
- 4.10.1 Impax Laboratories Company Information
- 4.10.2 Impax Laboratories Business Overview
- 4.10.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Impax Laboratories Oxycodone Product Portfolio
- 4.10.5 Impax Laboratories Recent Developments
- 4.11 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
- 4.11.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
- 4.11.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
- 4.11.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Portfolio
- 4.11.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Developments
- 4.12 Endo International
- 4.12.1 Endo International Company Information
- 4.12.2 Endo International Business Overview
- 4.12.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Endo International Oxycodone Product Portfolio
- 4.12.5 Endo International Recent Developments
5 Global Oxycodone Market Scenario by Region
- 5.1 Global Oxycodone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oxycodone Sales by Region: 2021-2032
- 5.2.1 Global Oxycodone Sales by Region: 2021-2026
- 5.2.2 Global Oxycodone Sales by Region: 2027-2032
- 5.3 Global Oxycodone Revenue by Region: 2021-2032
- 5.3.1 Global Oxycodone Revenue by Region: 2021-2026
- 5.3.2 Global Oxycodone Revenue by Region: 2027-2032
- 5.4 North America Oxycodone Market Facts & Figures by Country
- 5.4.1 North America Oxycodone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oxycodone Sales by Country (2021-2032)
- 5.4.3 North America Oxycodone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oxycodone Market Facts & Figures by Country
- 5.5.1 Europe Oxycodone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oxycodone Sales by Country (2021-2032)
- 5.5.3 Europe Oxycodone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oxycodone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oxycodone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oxycodone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oxycodone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oxycodone Market Facts & Figures by Country
- 5.7.1 South America Oxycodone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oxycodone Sales by Country (2021-2032)
- 5.7.3 South America Oxycodone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oxycodone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oxycodone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oxycodone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oxycodone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oxycodone Sales by Type (2021-2032)
- 6.1.1 Global Oxycodone Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Oxycodone Sales Market Share by Type (2021-2032)
- 6.2 Global Oxycodone Revenue by Type (2021-2032)
- 6.2.1 Global Oxycodone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oxycodone Revenue Market Share by Type (2021-2032)
- 6.3 Global Oxycodone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oxycodone Sales by Application (2021-2032)
- 7.1.1 Global Oxycodone Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Oxycodone Sales Market Share by Application (2021-2032)
- 7.2 Global Oxycodone Revenue by Application (2021-2032)
- 7.2.1 Global Oxycodone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oxycodone Revenue Market Share by Application (2021-2032)
- 7.3 Global Oxycodone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oxycodone Value Chain Analysis
- 8.1.1 Oxycodone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oxycodone Production Mode & Process
- 8.2 Oxycodone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oxycodone Distributors
- 8.2.3 Oxycodone Customers
9 Global Oxycodone Analyzing Market Dynamics
- 9.1 Oxycodone Industry Trends
- 9.2 Oxycodone Industry Drivers
- 9.3 Oxycodone Industry Opportunities and Challenges
- 9.4 Oxycodone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst